These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35780096)

  • 1. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
    Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
    BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
    Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
    EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.
    Rieger I; Tsintari V; Overkamp M; Fend F; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
    Front Mol Biosci; 2021; 8():727203. PubMed ID: 34805267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.
    Zhan M; Yu D; Lang A; Li L; Pollock RE
    Cancer; 2001 Sep; 92(6):1556-66. PubMed ID: 11745235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.
    Van Hook K; Wang Z; Chen D; Nold C; Zhu Z; Anur P; Lee HJ; Yu Z; Sheppard B; Dai MS; Sears R; Spellman P; Lopez CD
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1271-1277. PubMed ID: 27939881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
    Tomek S; Koestler W; Horak P; Grunt T; Brodowicz T; Pribill I; Halaschek J; Haller G; Wiltschke C; Zielinski CC; Krainer M
    Eur J Cancer; 2003 Jun; 39(9):1318-29. PubMed ID: 12763223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.
    Schittenhelm MM; Illing B; Ahmut F; Rasp KH; Blumenstock G; Döhner K; Lopez CD; Kampa-Schittenhelm KM
    PLoS One; 2013; 8(11):e80193. PubMed ID: 24312201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
    Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
    Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma.
    Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A
    Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
    BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
    Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
    J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
    Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
    J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
    Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
    Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
    Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
    Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53.
    Grellety T; Laroche-Clary A; Chaire V; Lagarde P; Chibon F; Neuville A; Italiano A
    BMC Cancer; 2015 Oct; 15():684. PubMed ID: 26463477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.